Concepedia

Chengfei Liu

CL

Statistics

Publications

47

Citations

3K

H-Index

29

Active since

2011

Affiliations

University of California, Davis(Current)

UC Davis Comprehensive Cancer Center

VA Northern California Health Care System

Second Affiliated Hospital of Xi'an Jiaotong University

King's College London

Chengfei Liu is an author at University of California, Davis specializing in medicine, urology, and tumor biology.

ORCID

Top concepts

Publications per year

2011–2024

47

Publications

47

Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Clinical Cancer Research · 2014 · 351 citations · Full text

Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Cancer Research · 2015 · 239 citations · Full text

, , +11

NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

Nagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu et al. · Molecular Cancer Therapeutics · 2013 · 182 citations · Full text

EXPRESSION OF CONCERN: Functional p53 determines docetaxel sensitivity in prostate cancer cells

Chengfei Liu, Yezi Zhu, Wei Lou et al. · The Prostate · 2012 · 122 citations · Full text

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer

Chengfei Liu, Wei Lou, Joy C. Yang et al. · Nature Communications · 2018 · 121 citations · Full text

1–5 of 47